A Study to Evaluate the Effect of an Acidic Formulation of Acalabrutinib (ACP-196), Acidic Beverage, or Grapefruit Juice on the Pharmacokinetics (PK) of ACP-196 Alone and Coadministered with Omeprazole

Trial Identifier: ACE-HV-112
Sponsor: Acerta Pharma BV
NCTID:: NCT04876807
Start Date: January 2016
Primary Completion Date: March 2016
Study Completion Date: March 2016
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
USA, Nebraska Lincoln, Nebraska, USA, (402) 437-483